CN Stock MarketDetailed Quotes
002644 Lanzhou Foci Pharmaceutical
- 8.43
- -0.27-3.10%
Market Closed Dec 13 15:00 CST
4.30BMarket Cap93.67P/E (TTM)
8.64High8.41Low103.80KlotVolume8.64Open8.70Pre Close88.31MTurnover2.03%Turnover Ratio63.86P/E (Static)510.66MShares10.1752wk High2.43P/B4.30BFloat Cap5.8152wk Low9.57Limit Up510.66MShs Float26.88Historical High7.83Limit Down2.64%Amplitude2.15Historical Low0.03Dividend TTM8.51Avg Price68.48KlotAsk0.36%Div YieldTTM100Lot Size33.17KlotBid
Lanzhou Foci Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -27.71%525.94M | -22.50%392.87M | -36.12%158.36M | 7.22%926.78M | 8.25%727.51M | 7.05%506.93M | 30.57%247.91M | 31.01%864.36M | 28.00%672.06M | 7.84%473.54M |
| Refunds of taxes and levies | -46.46%4.05M | 105.78%4.05M | -0.88%875.42K | 57.00%7.62M | 119.30%7.56M | -27.46%1.97M | 21.07%883.21K | -15.07%4.86M | -33.40%3.45M | -9.00%2.71M |
| Cash received relating to other operating activities | -27.64%26.93M | -57.91%13.91M | -29.10%20.6M | -4.31%42.76M | 99.73%37.22M | 124.12%33.06M | 289.85%29.05M | 47.27%44.68M | -67.29%18.64M | -50.25%14.75M |
| Cash inflows from operating activities | -27.89%556.92M | -24.19%410.83M | -35.28%179.83M | 6.92%977.16M | 11.26%772.28M | 10.38%541.95M | 40.30%277.84M | 31.34%913.9M | 18.22%694.14M | 4.09%491M |
| Goods services cash paid | -35.32%308.42M | -26.38%229.6M | -32.39%102.29M | 5.67%471.32M | -1.55%476.85M | 13.56%311.86M | 39.56%151.3M | 22.02%446.02M | 76.36%484.35M | 2.65%274.63M |
| Staff behalf paid | -15.48%113.71M | -14.31%81.38M | -19.79%43.49M | 9.46%194.17M | 19.43%134.54M | 38.79%94.97M | 56.57%54.23M | 5.35%177.4M | 16.41%112.66M | 6.16%68.43M |
| All taxes paid | -32.39%65.23M | -34.31%52.75M | -56.16%21.57M | 47.96%108.75M | 70.07%96.48M | 93.08%80.3M | 168.73%49.21M | -12.62%73.5M | 8.62%56.73M | 8.29%41.59M |
| Cash paid relating to other operating activities | -30.17%85.73M | -37.61%53.86M | 5.49%28.55M | 5.24%137.2M | 25.77%122.77M | 47.86%86.33M | 172.65%27.06M | 97.65%130.38M | 13.02%97.62M | 34.61%58.39M |
| Cash outflows from operating activities | -31.01%573.09M | -27.18%417.6M | -30.48%195.9M | 10.17%911.45M | 10.55%830.64M | 29.44%573.47M | 64.52%281.8M | 20.95%827.29M | 47.32%751.35M | 7.07%443.03M |
| Net cash flows from operating activities | 72.27%-16.18M | 78.54%-6.76M | -306.33%-16.07M | -24.12%65.71M | -2.01%-58.36M | -165.70%-31.51M | -114.78%-3.96M | 630.58%86.61M | -174.13%-57.21M | -17.22%47.97M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | --8M | --8M | --8M | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | ---- | --16.35K | --16.35K | --0 | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --11.5K | --11.5K | ---- | -91.84%3.1K | ---- | ---- | --0 | -99.91%38K | ---- | ---- |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | 135.97%1.77M | ---- | ---- | --2M | --750.19K | ---- | ---- |
| Cash inflows from investing activities | -99.86%11.5K | -99.86%11.5K | ---- | 1,139.97%9.77M | --8.02M | --8.02M | --2M | -99.01%788.19K | ---- | ---- |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -4.74%8.79M | 29.84%7.56M | -86.59%2.09M | -45.88%22.47M | -47.41%9.23M | -65.67%5.82M | 1,016.61%15.59M | 26.58%41.53M | -55.99%17.55M | -24.60%16.96M |
| Cash paid to acquire investments | ---- | ---- | ---- | 181.69%6M | 4,515.38%6M | --6M | ---- | -45.86%2.13M | -99.88%130K | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --15.46M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -42.27%8.79M | -36.06%7.56M | -86.59%2.09M | 0.62%43.93M | -13.85%15.23M | -30.29%11.82M | 1,016.61%15.59M | 18.83%43.66M | -88.42%17.68M | -83.45%16.96M |
| Net cash flows from investing activities | -21.75%-8.78M | -98.34%-7.55M | 84.61%-2.09M | 20.32%-34.16M | 59.21%-7.21M | 77.56%-3.81M | -873.34%-13.59M | -200.51%-42.87M | 76.88%-17.68M | 68.32%-16.96M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -90.00%50K | ---- | ---- | -87.07%500K | --500K | --500K | --500K | 17.15%3.87M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -90.00%50K | ---- | ---- | -87.07%500K | --500K | ---- | --500K | 17.15%3.87M | ---- | ---- |
| Cash from borrowing | -36.14%10M | ---- | ---- | 886.92%25.66M | --15.66M | --15.66M | ---- | --2.6M | ---- | ---- |
| Cash inflows from financing activities | -37.81%10.05M | ---- | ---- | 304.58%26.16M | --16.16M | --16.16M | --500K | 95.94%6.47M | ---- | ---- |
| Borrowing repayment | 74.63%23.4M | 0.00%13.4M | -1.16%13.89M | -24.22%21.45M | 0.00%13.4M | -5.72%13.4M | -1.15%14.05M | -19.73%28.31M | -60.58%13.4M | -57.70%14.21M |
| Dividend interest payment | -38.73%16.11M | -39.31%15.96M | ---- | 293.89%27.94M | 344.23%26.3M | 414.93%26.3M | ---- | -88.45%7.09M | -90.45%5.92M | 937.43%5.11M |
| Cash payments relating to other financing activities | ---- | ---- | ---- | 1,353.09%1.76M | ---- | ---- | ---- | --121.27K | ---- | ---- |
| Cash outflows from financing activities | -0.47%39.51M | -26.04%29.36M | -1.16%13.89M | 44.00%51.16M | 105.47%39.7M | 105.47%39.7M | -1.15%14.05M | -63.26%35.53M | -79.87%19.32M | -43.33%19.32M |
| Net cash flows from financing activities | -25.18%-29.46M | -24.74%-29.36M | -2.49%-13.89M | 13.97%-25M | -21.82%-23.54M | -21.82%-23.54M | 4.67%-13.55M | 68.89%-29.06M | 78.05%-19.32M | 26.15%-19.32M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | -3.62%674.48K | ---- | ---- | ---- | 437.13%699.79K | ---- | ---- |
| Net increase in cash and cash equivalents | 38.93%-54.42M | 25.80%-43.67M | -3.08%-32.05M | -52.97%7.23M | 5.41%-89.1M | -603.54%-58.86M | -378.88%-31.09M | 139.32%15.38M | -7.88%-94.2M | 153.69%11.69M |
| Add:Begin period cash and cash equivalents | 2.06%406.04M | 2.06%406.04M | 1.86%396.32M | 4.11%389.08M | 6.69%397.85M | 6.91%397.85M | 4.33%389.08M | -9.30%373.71M | -9.49%372.92M | -9.68%372.13M |
| End period cash equivalent | 13.89%351.62M | 6.89%362.37M | 1.75%364.26M | 1.86%396.32M | 10.77%308.75M | -11.68%339M | -6.79%357.99M | 4.33%389.08M | -14.16%278.72M | -1.65%383.82M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lianda Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lianda Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
